Related Experiment Video

Updated: Sep 21, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Inhibitory actions of genistein in human breast cancer (MCF-7) cells

Wen-Fang Chen1, Ming-Hui Huang, Chi-Hung Tzang

  • 1Central Laboratory of the Institute of Molecular Technology for Drug Discovery and Synthesis, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong SAR, PR China.

Biochimica Et Biophysica Acta
|July 11, 2003
PubMed

Insights

Genistein, a soy phytoestrogen, inhibits human breast cancer cell growth by affecting cell cycle phases. Its action involves regulating heat shock protein 105 (HSP) and serum response factor (SRF) mRNA, with partial estrogen receptor involvement.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Genistein, a soy isoflavonoid, is recognized for potential breast cancer prevention.
  • The precise molecular mechanisms underlying genistein's anti-cancer effects remain incompletely elucidated.

Purpose of the Study:

  • To investigate the molecular mechanisms of genistein's inhibitory action on MCF-7 human breast cancer cells.
  • To identify genes differentially regulated by genistein treatment.

Main Methods:

  • MCF-7 cell culture and treatment with genistein (50 and 100 microM).
  • Cell cycle analysis using flow cytometry.
  • Gene expression profiling via cDNA microarray and validation with reverse transcriptase-polymerase chain reaction (RT-PCR) and real-time RT-PCR.
  • Protein expression analysis using Western blotting.

Main Results:

  • Genistein significantly arrested MCF-7 cells at the G2/M phase and reduced S phase proliferation.
  • Genistein up-regulated heat shock protein 105 (HSP) mRNA and down-regulated serum response factor (SRF), estrogen receptor (ER) alpha, disabled homolog 2 (DOC 2), and recombination activation gene 1 (RAG-1) mRNA.
  • Genistein's effects on SRF mRNA were partially reversible with estrogen antagonist ICI 182,780, but HSP mRNA regulation was not.
  • Western blotting confirmed decreased ERalpha and SRF protein levels following genistein treatment.

Conclusions:

  • Genistein exhibits inhibitory effects on human breast cancer cells.
  • These effects are complex and only partially mediated through estrogen receptor-dependent pathways.
  • Genistein modulates the expression of key genes including HSP and SRF, contributing to its anti-cancer activity.

More Related Videos

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...